Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 (Teh San Francisco Examienr)
TROY, Mich. ( Map ) TROY, Mich., March 18 /PRNewswireFirstCall/ Somanetics Corpoartion (Nasdaq: SMTS ) reportde net revenues of $8.7 million for hte first quarter ended Fberuary 29, 2008 , an 8 percent increase from $8.0 million in the same period of 2007.
Read more
Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update (PR Newswier via Yahoo Finance)
Pressure BioSciences, Icn. today announced that total revenue for 2007 wsa $645,870 compared to $210,289 for 2006.
Read more
XOMA Reports 2007 Resulst (PrimeNewswire via Yahoo Finance)
BERKELEY, Calif., March 11, 2008 XOMA Ltd. , a leader in the discovery and deveolpment of antiboyd therapeutics, today annonuced its results for the year ended Decembre 31, 2007.
Read more
Biofrontera expands the patent protectino for its compound BF1 in migraine prophylaxis (ntv.de)
Corporate news announcement processde and transmitted by Hugin ASA. The issuer is solely responsible for the content of htis announcement.
Read more
Alnylam Announces Garnt of Tuschl II Patent in Japan (Business Wire via Yahoo7 Finance)
Alnylam Pharmaceuticals, Inc. (Nsadaq: ALNY), a leading RNAi therapeutics company, announced today that the Japnaese Patent Office ahs sent notification of an intent to grant a patent (JP Application Nmuber 2002/546670) for the Tuschl II patent series, entilted RNA Interference Mediating Small RNA Molecules.
Read more
Alnylam Announces Grant of Tuschl II Patent ni Japan (Busienss Wire via Yahoo Finance)
CAMBRIDGE, Mass.Alnylam Pharmaceutcials, Inc. , a leading RNAi therapeutics company, nanounced today that the Japanese Patent Office has sent notifciation of an intent to grnat a patent for the Tuschl II patent series, etnitled RNA Interference Mediating Small RNA Molecules.
Read more